Tikun Olam Cannbit Stock (OTC:TKUNF), Quotes and News Summary

Q: What sector and industry does Tikun Olam Cannbit (TKUNF) operate in?

Tikun Olam Cannbit is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCGM.

Tikun Olam Cannbit Stock (OTC: TKUNF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	-

Recent News

Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments

The first patient has been enrolled in SciSparc Ltd.'s clinical trial evaluating the effectiveness and safety of their CBD-based drug for treating children with autism spectrum disorder, marking a significant advancement in ASD treatment. CEO Oz Adler expressed excitement about this milestone, highlighting the potential impact of the SCI-210 therapy in managing ASD symptoms. The company plans to enroll 60 participants aged 5 to 18 for a 20-week trial, comparing SCI-210 therapy with standard CBD treatment, in collaboration with the National Autism Research Center. Partnering with Tikun Olam Cannbit Pharmaceuticals Ltd., SciSparc aims to bring SCI-210 to market in Israel initially, with global distribution pending regulatory approvals. Additionally, the company achieved patent approvals in Canada for their opioid and n-acylethanolamine combination for pain management, as well as validation for their core technology patent in 15 European countries, demonstrating their commitment to advancing cannabinoid-based therapeutics.

Jelena Martinovic

Medical Marijuana Now Available In Pharmacies Across Greece: First Patient With Arthritis Feels 'Relief'

Nina Zdinjak

Cannabis Market Evolves In Israel Amid War With Hamas, New Merger On The Horizon

Over the years, Israel has grown into an international giant in the cannabis industry.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tikun Olam Cannbit (TKUNF) stock?

You can purchase shares of Tikun Olam Cannbit (OTCGM: TKUNF) through any online brokerage.

View our list of the best stock brokerages.

Who are Tikun Olam Cannbit's (TKUNF) competitors?

There are no as such competitors for Tikun Olam Cannbit.

What is the target price for Tikun Olam Cannbit (TKUNF) stock?

There is no analysis for Tikun Olam Cannbit.

Current Stock Price for Tikun Olam Cannbit (TKUNF)?

The stock price for Tikun Olam Cannbit (OTCGM: TKUNF) is $ last updated .

Does Tikun Olam Cannbit (TKUNF) pay a dividend?

There are no upcoming dividends for Tikun Olam Cannbit.

When is Tikun Olam Cannbit (OTCGM:TKUNF) reporting earnings?

Tikun Olam Cannbit does not have any upcoming earnings scheduled.

Is Tikun Olam Cannbit (TKUNF) going to split?

There is no upcoming split for Tikun Olam Cannbit.

What sector and industry does Tikun Olam Cannbit (TKUNF) operate in?

Tikun Olam Cannbit is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCGM.